Despite Kennedy's anti-vaccine history, which greatly alarms professionals in the health sector, some see his promises to improve Americans' diets as a step in the right direction. Also, with Kennedy's hearings scheduled for this week,

Agencies subject to the HHS directive include the CDC ... president of the Center for Science in the Public Interest. “When it comes to stopping outbreaks, every second counts,” Lurie said ...

The CDC manages updates on bird flu in humans, and the FDA is responsible for sending alerts related to food safety outbreaks and recalls.

In his second day of confirmation hearings, Robert F. Kennedy Jr., President Donald Trump’s pick to lead the Department of Health and Human Services, refused to say that vaccines do not cause autism -- despite a large body of evidence showing there is no link.

The National Science Foundation's funding freeze, and wider confusion about the status and future of science funding, is already hampering research.

Readers and medical professionals discuss the Trump administration halting communication and travel at HHS. Regarding the Jan. 24 front-page article “ Health officials left with ‘chaos’ as HHS goes silent ”:

Robert F. Kennedy Jr. sounded concern on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs being a silver bullet for curing the obesity epidemic in the US.

Plus: Bringing astronauts back from the ISS, fixing hearts with space-grown cells, why your kids need to touch grass and more.

Kennedy also is a big time believer of drinking raw milk, which he believes has more health benefits, despite the increased risk of bacterial contamination. He has also lead to more controversies on health issues including fluoride in drinking water,

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts and inflict lasting damage on institutional credibility.

Billed as the most significant change to the science system in 30 years, last week's announcement of major structural changes to scientific research institutions was objectively a big deal.

Three of Trump’s most controversial nominees will testify before the Senate in what could be a make-or-break moment for his administration picks.